MicroRNA-889-3p restrains the proliferation and epithelial–mesenchymal transformation of lung cancer cells via down-regulation of Homeodomain-interacting protein kinase 1

References

• Forde PM, Chaft JE, Smith KN, et al. Neoadjuvant PD-1 blockade in resectable lung cancer. N Engl J Med. 2018;378(21):1976–1986.
   PubMed Web of Science ®Google Scholar
• Bai Y, Zhang G, Cheng R, et al. CASC15 contributes to proliferation and invasion through regulating miR-766-5p/ KLK12 axis in lung cancer. Cell Cycle (Georgetown, Tex). 2019;18(18):2323–2331.
   PubMed Web of Science ®Google Scholar
• Morris S, Vachani A, Pass HI, et al. Whole blood FPR1 mRNA expression predicts both non-small cell and small cell lung cancer. Int J Cancer. 2018;142(11):2355–2362.
   PubMed Web of Science ®Google Scholar
• Cai YJ, Zheng XF, Lu CH, et al. Effect of FUT3 gene silencing with miRNA on proliferation, invasion and migration abilities of human KATO-III gastric cancer cell line. Cell Mol Biol (Noisy-le-grand). 2016 [2016 07 28];62:15–20.
   PubMed Web of Science ®Google Scholar
• Yu Q, Yang X, Duan W, et al. miRNA-346 promotes proliferation, migration and invasion in liver cancer. Oncol Lett. 2017;14(3):3255–3260.
   PubMed Web of Science ®Google Scholar
• Bajan S, Hutvagner G. Regulation of miRNA processing and miRNA mediated gene repression in cancer. MicroRNA (Shariqah, United Arab Emirates). 2014;3:10–17. 2014 07 30.
   PubMedGoogle Scholar
• Lin Z, Li JW, Wang Y, et al. Abnormal miRNA-30e expression is associated with breast cancer progression. Clin Lab. 2016;62:121–128.
   PubMed Web of Science ®Google Scholar
• Wang LQ, Chim CS. DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia. Epigenomics. 2015;7(3):461–473.
   PubMed Web of Science ®Google Scholar
• Liu X, Xie S, Zhang J, et al. Long noncoding RNA XIST contributes to cervical cancer development through targeting miR-889-3p/SIX1 axis. Cancer Biother Radiopharm. 2020;35(9):640–649.
   PubMed Web of Science ®Google Scholar
• Conte A, Pierantoni GM. Update on the regulation of HIPK1, HIPK2 and HIPK3 protein kinases by microRNAs. MicroRNA (Shariqah, United Arab Emirates). 2018;7:178–186. 2018 05 26.
   PubMedGoogle Scholar
• Liu B, Du R, Zhou L, et al. miR-200c/141 regulates breast cancer stem cell heterogeneity via targeting HIPK1/β-catenin axis. Theranostics. 2018;8(21):5801–5813.
   PubMed Web of Science ®Google Scholar
• Gasior K, Wagner NJ, Cores J, et al. The role of cellular contact and TGF-beta signaling in the activation of the epithelial mesenchymal transition (EMT). Cell Adh Migr. 2019;13(1):63–75.
   PubMed Web of Science ®Google Scholar
• Solheim O, Førsund M, Tropé CG, et al. Epithelial-mesenchymal transition markers in malignant ovarian germ cell tumors. APMIS. 2017;125(9):781–786.
   PubMed Web of Science ®Google Scholar
• Sun J, Yang X, Zhang R, et al. GOLPH3 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in epithelial ovarian cancer. Cancer Med. 2017;6(4):834–844.
   PubMed Web of Science ®Google Scholar
• Yu SZ, Hua SS. CircPTCH1 promotes migration in lung cancer by regulating MYCN expression through miR-34c-5p.[J]. Onco Targets Ther. 2021;14:4779–4789.
   PubMed Web of Science ®Google Scholar
• Junyu R, Ning X, Ruize Z, et al. Long non-coding RNA PCED1B antisense RNA 1 promotes gastric cancer progression via modulating microRNA-215-3p/C-X-C motif chemokine receptor 1 axis.[J]. Bioengineered. 2021;12(1):6083–6095.
   PubMed Web of Science ®Google Scholar
• Songda C, Huijie W, Lingyu Z, et al. MiR-199b-5p promotes gastric cancer progression by regulating HHIP expression.[J]. Front Oncol. 2021;11:728393.
   PubMedGoogle Scholar
• Yiwang Y, Xuan W, Feihu L, et al. Circular RNA _0015278 inhibits the progression of non-small cell lung cancer through regulating the microRNA 1278/SOCS6 gene axis.[J]. Ann Transl Med. 2021;9(15):1255.
   PubMed Web of Science ®Google Scholar
• Nan C, Xuedan Z, Yinxing Z, et al. The regulatory relationship and function of LncRNA FAM225A-miR-206-ADAM12 in gastric cancer.[J]. Am J Transl Res. 2021;13:8632–8652.
   PubMed Web of Science ®Google Scholar
• Yang G, Chengtao L, Xiaoling Z, et al. hsa_circ_0000006 induces tumorigenesis through miR-361-3p targeting immunoglobulin-like domains protein 1 (LRIG1) in osteosarcoma.[J]. Ann Transl Med. 2021;9(15):1242.
   PubMed Web of Science ®Google Scholar
• Yibin Z, Hongyi Z, Jie S, et al. MiR-1236-3p inhibits the proliferation, invasion, and migration of colon cancer cells and hinders epithelial-mesenchymal transition by targeting DCLK3.[J]. Front Oncol. 2021;11:688882.
   PubMed Web of Science ®Google Scholar
• Hongtao L, Qing Z, Yinsen S, et al. Long non-coding RNA SLC2A1-AS1 induced by GLI3 promotes aerobic glycolysis and progression in esophageal squamous cell carcinoma by sponging miR-378a-3p to enhance Glut1 expression.[J]. J Exp Clin Cancer Res. 2021;40(1):287.
   PubMed Web of Science ®Google Scholar
• Jie W, Changjiang L, Pingping S, et al. LncRNA DCST1-AS1 promotes endometrial cancer progression by modulating the MiR-665/HOXB5 and MiR-873-5p/CADM1 pathways.[J]. Front Oncol. 2021;11:714652.
   PubMed Web of Science ®Google Scholar
• Xinyu W, Daoyan L, Shuzhen W, et al. Circ_0007444 inhibits the progression of ovarian cancer via mediating the miR-570-3p/PTEN axis.[J]. Onco Targets Ther. 2021;14:97–110.
   PubMed Web of Science ®Google Scholar
• Li P, Wang Q, Wang H. MicroRNA-204 inhibits the proliferation, migration and invasion of human lung cancer cells by targeting PCNA-1 and inhibits tumor growth in vivo. Int J Mol Med. 2019 2019 01 11;43:1149–1156.
   PubMed Web of Science ®Google Scholar
• Wang J, Shi C, Wang J, et al. MicroRNA-320a is downregulated in non-small cell lung cancer and suppresses tumor cell growth and invasion by directly targeting insulin-like growth factor 1 receptor. Oncol Lett. 2017;13(5):3247–3252.
   PubMed Web of Science ®Google Scholar
• Lin J, Wang Y, Zou YQ, et al. Differential miRNA expression in pleural effusions derived from extracellular vesicles of patients with lung cancer, pulmonary tuberculosis, or pneumonia. Tumour Biol. 2016;37(12):15835–15845.
   Google Scholar
• Tavasolian F, Hosseini AZ, Soudi S, et al. A systems biology approach for miRNA-mRNA expression patterns analysis in rheumatoid arthritis. Comb Chem High Throughput Screen. 2021;24(2):195–212.
   PubMed Web of Science ®Google Scholar
• Brahmer J, Reckamp KL, Baas P, et al. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. N Engl J Med. 2015;373(2):123–135.
   PubMed Web of Science ®Google Scholar
• Pérol M, Ciuleanu TE, Arrieta O, et al. Quality of life results from the phase 3 REVEL randomized clinical trial of ramucirumab-plus-docetaxel versus placebo-plus-docetaxel in advanced/metastatic non-small cell lung cancer patients with progression after platinum-based chemotherapy. Lung Cancer. 2016;93:95–103. 2016 02 24.
   PubMed Web of Science ®Google Scholar
• Liang L, Fu J, Wang S, et al. MiR-142-3p enhances chemosensitivity of breast cancer cells and inhibits autophagy by targeting HMGB1. Acta Pharm Sin B. 2020;10(6):1036–1046.
   PubMed Web of Science ®Google Scholar
• Macfarlane LA, Murphy PR. MicroRNA: Biogenesis, function and role in cancer. Curr Genomics. 2010;11(7):537–561.
   PubMed Web of Science ®Google Scholar
• Takamizawa J, Konishi H, Yanagisawa K, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004;64(11):3753–3756.
   PubMed Web of Science ®Google Scholar
• Molina-Pinelo S, Carnero A, Rivera F, et al. MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer. BMC Cancer. 2014;14(1):656.
   PubMedGoogle Scholar
• Qi Y, Cui L, Ge Y, et al. Altered serum microRNAs as biomarkers for the early diagnosis of pulmonary tuberculosis infection. BMC Infect Dis. 2012;12(1):384.
   PubMedGoogle Scholar
• Sun Y, Cheng Y, Zhang Y, et al. MicroRNA-889-3p targets FGFR2 to inhibit cervical cancer cell viability and invasion. Exp Ther Med. 2019;18:1440–1448. 2019 07 19.
   PubMed Web of Science ®Google Scholar
• Xu Y, He J, Wang Y, et al. miR-889 promotes proliferation of esophageal squamous cell carcinomas through DAB2IP. FEBS Lett. 2015;589(10):1127–1135.
   PubMed Web of Science ®Google Scholar
• Ge D, Chen H, Zheng S, et al. Hsa-miR-889-3p promotes the proliferation of osteosarcoma through inhibiting myeloid cell nuclear differentiation antigen expression. Biomed Pharmacothe. 2019;114:108819. 2019 04 06.
   PubMed Web of Science ®Google Scholar
• Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science (New York, NY). 2011;331(6024):1559–1564.
   Google Scholar
• Ye X, Weinberg RA. Epithelial-mesenchymal plasticity: a central regulator of cancer progression. Trends Cell Biol. 2015;25(11):675–686.
   PubMed Web of Science ®Google Scholar
• Jung HY, Fattet L, Yang J. Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis. Clin Cancer Res off J Am Assoc Cancer Res. 2015;21(5):962–968.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297.
   PubMed Web of Science ®Google Scholar
• Akaike Y, Kuwano Y, Nishida K, et al. Homeodomain-interacting protein kinase 2 regulates DNA damage response through interacting with heterochromatin protein 1γ. Oncogene. 2015;34(26):3463–3473.
   PubMed Web of Science ®Google Scholar
• Choi CY, Kim YH, Kim YO, et al. Phosphorylation by the DHIPK2 protein kinase modulates the corepressor activity of Groucho. J Biol Chem. 2005;280(22):21427–21436.
   PubMed Web of Science ®Google Scholar
• Kim YH, Choi CY, Lee SJ, et al. Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. J Biol Chem. 1998;273(40):25875–25879.
   PubMed Web of Science ®Google Scholar
• Rey C, Soubeyran I, Mahouche I, et al. HIPK1 drives p53 activation to limit colorectal cancer cell growth. Cell Cycle (Georgetown, Tex). 2013;12(12):1879–1891.
   PubMed Web of Science ®Google Scholar